Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/GEKA stock hub

FRA/GEKA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/GEKAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

824.1M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/GEKAFRA/GEKA

—

Loading chart…

In the news

Latest news · FRA/GEKA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.6

P25 n/aP50 n/aP75 n/a

Trailing P/E10.7

P25 n/aP50 n/aP75 n/a

ROE14

P25 n/aP50 n/aP75 n/a

ROIC15.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/GEKA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

MXN

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Mexico
Country code	DE
Employees	1,465
Employees Change	43%
Employees Change Percent	2.58
Enterprise value	EUR 1.1B
Exchange	Frankfurt Stock Exchange
Financial currency	MXN
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 824.1M
Price	EUR 0.83
Price currency	EUR
Rev Per Employee	568,956.62x
Sic	2834
Symbol	fra/GEKA
Website	https://www.genommalab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.36%
EV Earnings	14.04x
EV/EBIT	5.97x
EV/EBITDA	5.42x
EV/FCF	15.86x
EV/Sales	1.27x
FCF yield	8.29%
Forward P/E	6.59x
P/B ratio	1.46x
P/E ratio	10.68x
P/S ratio	0.99x
PE Ratio10 Y	14.53x
PE Ratio3 Y	11.23x
PE Ratio5 Y	12.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.2%
EBITDA Margin	23.35%
FCF margin	8.19%
Gross margin	62.98%
Gross Profit	EUR 525M
Gross Profit Growth	-8.75%
Gross Profit Growth Q	-3.97%
Gross Profit Growth3 Y	2.23%
Gross Profit Growth5 Y	4.62%
Net Income	EUR 77.1M
Net Income Growth	-27.7%
Net Income Growth Q	-0.82%
Net Income Growth3 Y	4.42%
Net Income Growth5 Y	2.51%
Pretax Margin	13.72%
Profit Margin	9.25%
Profit Per Employee	EUR 52,652
ROA	9.39
Roa5y	9.8
ROCE	21.42
ROE	14.05
Roe5y	14.74
ROIC	15.09
Roic5y	15.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.76%
Cagr15y	-2.97%
Cagr1y	-8.74%
Cagr3y	8.26%
Cagr5y	4.56%
Div CAGR3	7.71%
EPS Growth	-26.7
EPS Growth Q	-0.7
EPS Growth3 Y	4.74
EPS Growth5 Y	3.18
FCF Growth	-47.01%
FCF Growth3 Y	14.19%
FCF Growth5 Y	18.86%
OCF Growth	-34.32%
OCF Growth10 Y	12.91%
OCF Growth3 Y	13.62%
OCF Growth5 Y	8.47%
Revenue Growth	-7.92x
Revenue Growth Q	-4.9x
Revenue Growth3 Y	0.67x
Revenue Growth5 Y	4.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.71
Assets	EUR 1.2B
Cash	EUR 135.1M
Current Assets	EUR 674.4M
Current Liabilities	EUR 377.7M
Debt	EUR 387.7M
Debt EBITDA	EUR 1.99
Debt Equity	EUR 0.69
Debt FCF	EUR 5.68
Equity	EUR 563.6M
Interest Coverage	4.87
Liabilities	EUR 629.5M
Long Term Assets	EUR 518.8M
Long Term Liabilities	EUR 251.8M
Net Cash	EUR -252.5M
Net Cash By Market Cap	EUR -30.64
Net Debt EBITDA	EUR 1.3
Net Debt Equity	EUR 0.45
Net Debt FCF	EUR 3.7
Tangible Book Value	EUR 293.1M
Tangible Book Value Per Share	EUR 0.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.79
Inventory Turnover	3.08
Net Working Capital	EUR 314.1M
Quick ratio	1.44
Working Capital	EUR 289.1M
Working Capital Turnover	EUR 0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.37%
Dividend Growth	-1.27%
Dividend Growth Years	0%
Dividend per share	EUR 0.04
Dividend Years	6
Dividend Yield	4.5%
Ex Div Date	2026-03-30
Last Dividend	EUR 0.01
Payout Frequency	Quarterly
Payout Ratio	48.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	19.11%
1Y total return	-8.74%
200-day SMA	0.86
3Y total return	26.88%
50-day SMA	0.85
50-day SMA vs 200-day SMA	50under200
5Y total return	24.95%
All Time High	2.17
All Time High Change	-61.68%
All Time High Date	2013-12-06
All Time Low	0.15
All Time Low Change	449.67%
All Time Low Date	2009-03-20
ATR	0.02
Ch YTD	0.61
High	0.83
High52	1.09
High52 Date	2025-08-12
High52ch	-23.85%
Low	0.83
Low52	0.76
Low52 Date	2026-03-23
Low52ch	9.21%
Ma50ch	-2.24%
Price vs 200-day SMA	-3.8%
RSI	49.32
RSI Monthly	45.89
RSI Weekly	46.86
Sharpe ratio	-0.05x
Sortino ratio	0.06
Total Return	5.88%
Tr YTD	1.79
Tr15y	-36.39%
Tr1m	-5.14%
Tr1w	5.73%
Tr3m	9.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 176.7M
Operating Income Growth	-8.55
Operating Income Growth Q	-8.97
Operating Income Growth3 Y	3.93
Operating Income Growth5 Y	5.47
Operating margin	21.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	674,252,233%
Net Borrowing	55,299,437.8
Shares Insiders	30.96%
Shares Institutions	26.09%
Shares Qo Q	0.69%
Shares Yo Y	-1.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 68.3M
Average Volume	37.65x
Bv Per Share	0.56
CAPEX	EUR -26.8M
Ch10y	-2.92
Ch15y	-48.16
Ch1m	-5.14
Ch1w	5.73
Ch1y	-12.63
Ch3m	7.79
Ch3y	10.67
Ch5y	1.84
Ch6m	1.22
Change	3.11%
Change From Open	0
Close	0.81
Days Gap	3.11
Depreciation Amortization	18,404,629.8
Earnings Date	2026-04-22
EBIT	EUR 176.7M
EBITDA	EUR 194.7M
EPS	EUR 0.08
F Score	5
FCF	EUR 68.3M
FCF EV Yield	6.3x
Financing CF	-20,148,175
Fiscal Year End	December
Founded	1,996
Graham Number	0.99616
Graham Upside	20.02
Income Tax	EUR 37.2M
Investing CF	-35,807,287
Is Primary Listing	0
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2010-08-03
Last Split Type	Forward
Lynch Fair Value	EUR 0.39
Lynch Upside	-53.2
Ma150	0.83
Ma150ch	-0.3%
Ma20	0.85
Ma20ch	-2.12%
Net CF	25,384,669
Open	0.83
P FCF Ratio	12.07
P OCF Ratio	8.67
Payment Date	2026-03-31
Ppne	199,532,257.1
Price Date	2026-05-08
Price EBITDA	EUR 4.23
Ptbv Ratio	2.81
Relative Volume	2.34x
Revenue	833,521,441x
Tax By Revenue	4.46x
Tax Rate	32.54%
Tr6m	3.63%
Volume	0
Z Score	3.07

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/GEKA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.5%

$0.04 annual per share

Payout ratio

+48.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+5.9%

Next ex-dividend date: 2026-03-30

Performance

FRA/GEKA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/GEKA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.1%

Share of float held by funds and institutions

Insider ownership

+31.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.4%

Negative means the company is buying back shares.

Technical

FRA/GEKA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.3

Neutral momentum band

Price vs 200-day MA

-3.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/GEKA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/GEKA stock rating?

fra/GEKA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/GEKA analysis?

The full report lives at /stocks/fra/GEKA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/GEKA?

The latest report frames fra/GEKA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/GEKA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.